The largest database of trusted experimental protocols

Cobas mira chemistry analyzer

Manufactured by Roche

The Cobas-Mira Chemistry Analyzer is a compact, automated clinical chemistry analyzer. It is designed to perform a variety of routine clinical chemistry tests on patient samples. The Cobas-Mira can analyze different types of samples, including serum, plasma, and urine. It is capable of processing multiple samples simultaneously and provides fast, reliable results.

Automatically generated - may contain errors

6 protocols using cobas mira chemistry analyzer

1

Serum Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were fasted for 16 h, anaesthetized with isoflurane and blood was collected by cardiac puncture and kept for 30 min at room temperature to promote clot formation. Serum was prepared by cold centrifugation at 3000g for 20 min. Serum was stored at −20° C until use. Serum glucose was determined using routine methods using commercial reagents (Roche) on a Cobas 6000 analyzer (Roche). Fructosamine levels were determined on a Cobas-Mira Chemistry Analyzer using the Roche reagents (Roche). Triglyceride levels were determined with the EnzyChrom Triglyceride Assay Kit (BioAssay Systems) according to the manufacturer's instructions.
+ Open protocol
+ Expand
2

Biomarker Measurement and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected on the first day and last day of each intervention period after a 12–hour fast by trained research staff. Specimens were locally processed and stored at −80°C until analyses. Glucose was measured on a Roche Module P chemistry autoanalyzer (Roche Diagnostic Inc., Indianapolis, IN) at the Northwest Lipid Research Laboratories (University of Washington, WA). Insulin was measured using a Tosoh 2000 autoanalyzer (Tosoh Biosciences Inc., South San Francisco, CA) at the Diabetes Endocrinology Research Center Immunoassay Laboratory (University of Washington, WA). The rest of the biomarkers assessments and the genotyping were conducted at the FHCRC Biomarker Core Laboratory and the Molecular Epidemiology Laboratories. Immunoassays were used to measured total adiponectin (Total Adiponectin EIA, Aplco), IGF-1 (Human IGF-I Quantikine ELISA, R&D Systems), IGFBP-3 (Human IGFBP-3 Quantikine ELISA, R&D Systems), and IL-6 (Human IL-6 Quantikine HS ELISA, R&D Systems). CRP was measured using CRP (3 (link))-Wide Range reagent (Kamiya Biomedical Company) on Roche Cobas Mira chemistry analyzer with a high sensitivity protocol. The intra-assay CVs were 0.7%, 7.8%, 1.3%, 1.5%, 1.8%, 2.3%, and 3.3% for glucose, insulin, adiponectin, IGF-1, IGFBP-3, IL-6, and CRP, respectively. The details of specimen collection and analysis have been previously described (14 (link)).
+ Open protocol
+ Expand
3

Biomarker Measurement and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected on the first day and last day of each intervention period after a 12–hour fast by trained research staff. Specimens were locally processed and stored at −80°C until analyses. Glucose was measured on a Roche Module P chemistry autoanalyzer (Roche Diagnostic Inc., Indianapolis, IN) at the Northwest Lipid Research Laboratories (University of Washington, WA). Insulin was measured using a Tosoh 2000 autoanalyzer (Tosoh Biosciences Inc., South San Francisco, CA) at the Diabetes Endocrinology Research Center Immunoassay Laboratory (University of Washington, WA). The rest of the biomarkers assessments and the genotyping were conducted at the FHCRC Biomarker Core Laboratory and the Molecular Epidemiology Laboratories. Immunoassays were used to measured total adiponectin (Total Adiponectin EIA, Aplco), IGF-1 (Human IGF-I Quantikine ELISA, R&D Systems), IGFBP-3 (Human IGFBP-3 Quantikine ELISA, R&D Systems), and IL-6 (Human IL-6 Quantikine HS ELISA, R&D Systems). CRP was measured using CRP (3 (link))-Wide Range reagent (Kamiya Biomedical Company) on Roche Cobas Mira chemistry analyzer with a high sensitivity protocol. The intra-assay CVs were 0.7%, 7.8%, 1.3%, 1.5%, 1.8%, 2.3%, and 3.3% for glucose, insulin, adiponectin, IGF-1, IGFBP-3, IL-6, and CRP, respectively. The details of specimen collection and analysis have been previously described (14 (link)).
+ Open protocol
+ Expand
4

Metabolic Biomarkers in Juvenile Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 9 months of age, one male from each litter was fasted overnight and blood was collected via cardiac puncture in heparinized tubes for analysis. Plasma insulin was measured using rat specific commercial radioimmunoassay kits (insulin RIA kit, LINCO Research Inc., St. Charles, MO). Plasma triglycerides were measured using Raichem Enzymatic Reagents (Cat No. 80008, Raichem, Inc., San Diego, CA) with control serum level 1 (#83082) and control serum level 2 (#83083) and run on an automated Cobas-Mira Chemistry Analyzer (Roche Diagnostic Systems Inc., Sommerville, NJ). Blood glucose determined using Hemocue B-Glucose Analyzer (HemoCue Inc, Mission Viejo, CA).
+ Open protocol
+ Expand
5

Diabetes Ascertainment in Aging Cohort

Check if the same lab product or an alternative is used in the 5 most similar protocols
At every study visit, diabetes classification was based on fasting glucose level ≥126 mg/dL, anti-diabetic medication use, or self-report of a physician diagnosis of diabetes at the baseline examination. Fasting glucose was measured with the Cobas Mira Chemistry Analyzer (Roche Diagnostics Corporation, Indianapolis, IN) and medication use was ascertained by inspection of medications. The majority (75.5%) of participants with diabetes at baseline met at least two criteria and 24.5% met one (10.8% fasting glucose level, 2.1% medication use, and 11.7% self-report). Due to the advanced age of the cohort, most diabetes cases are likely to be type 2 diabetes. At each wave, individuals were designated as having one of the following: baseline diabetes, diabetes at the current wave that was diagnosed since baseline (diabetes diagnosed during study), or no diabetes.
+ Open protocol
+ Expand
6

Plasma Hormone and Lipid Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma insulin, leptin and coritcosterone levels were measured using rat specific commercial radioimmunoassay kits (insulin and leptin RIA kit, LINCO Research Inc., St. Charles, MO; coritcosterone RIA Kit, Diagnostic Systems Laboratories, Inc, Webster, TX). Plasma lipid levels were measured using reagents from Raichem, Inc. (San Diego, CA) and run on an automated Cobas-Mira Chemistry Analyzer (Roche Diagnostic Systems Inc., Sommerville, NJ). Plasma triglycerides (Cat No. 80008) and cholesterol (Cat No. 80015) concentrations were analyzed using Raichem Enzymatic Reagents (with control serum level 1 #83082 and control serum level 2 #83083). Blood glucose determined using Hemocue B-Glucose Analyzer (HemoCue Inc, Mission Viejo, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!